Navigation Links
AAPS presents therapeutic protein drug interactions workshop
Date:5/3/2010

WHO: The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific society of approximately 12,000 members employed in industry, academia, government and other research institutes worldwide. Founded in 1986, AAPS provides a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to public health. AAPS offers timely scientific programs, on-going education, information resources, opportunities for networking, and professional development.

WHAT: AAPS is pleased to present the workshop on Strategies to Address Therapeutic Protein Drug Interactions during Clinical Development. This event will feature a review of pre-clinical tools, test systems, and relevant documented Therapeutic Protein (TP)-drug interactions. Case studies, study designs, and acceptance criteria for certain interactions in clinical studies will be addressed.

WHY: The purpose of this workshop is to provide participants with a clear understanding of how to develop strategies for the assessment of TP-drug interactions. This session will provide the opportunity for participants to interact with industry, academic, and regulatory representatives, and to participate in roundtable discussions on how to arrive at science-driven, risk-based approaches for assessing the potential for TP-drug interactions.

WHEN/WHERE: May 15-16, 2010
Hilton San Francisco Union Square
San Francisco, CA


'/>"/>

Contact: Joseph Catapano
catapanoj@aaps.org
703-248-4772
American Association of Pharmaceutical Scientists
Source:Eurekalert

Page: 1

Related biology news :

1. Frontiers in Optics presents scientific advancements
2. New book presents successful strategies for probing genetic variation
3. NARSAD presents 2007 prizes for outstanding achievement in neuroscience and psychiatric research
4. New book presents methods to poke and prod individual molecules
5. Internationally recognized experts presents a complete overview on hydroecology and ecohydrology
6. Researcher helping to pioneer medical therapy for Fragile X Syndrome presents latest findings
7. ICS presents prestigious Digby McLaren Medal to Cincinnatis Carl Brett
8. Penn presents inaugural symposium on applied mathematics and computational science
9. Soil Science Society of America presents 2008 fellows
10. Soil Science Society of America presents awards in Houston
11. Arbor Vita presents new data on cancer diagnostic at EUrogin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2016)... June 7, 2016  Syngrafii Inc. and San ... relationship that includes integrating Syngrafii,s patented LongPen™ eSignature ... This collaboration will result in greater convenience for ... union, while maintaining existing document workflow and compliance ... ...
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
(Date:5/24/2016)... facilitates superior patient care by providing unparalleled technology to leaders of the medical imaging ... product recently added to the range of products distributed by Ampronix. Photo ... ... ... News ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016   EpiBiome , a precision microbiome engineering ... debt financing from Silicon Valley Bank (SVB). The financing ... advance its drug development efforts, as well as purchase ... "SVB has been an incredible strategic partner to us ... bank would provide," said Dr. Aeron Tynes Hammack ...
(Date:6/23/2016)... ON (PRWEB) , ... June 23, 2016 , ... STACS ... DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as ... the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
Breaking Biology Technology: